Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ben Stanger"'
Autor:
Jessica Potts, Emily Corse, Joseph Tumang, Pratha Budhani, Abhishek Kashyap, Xiaoyun Liao, Candace Wai Sze Lei, John Holt, Brianna Flynn, Richard Barrett, Mohanapriya Kamalakannan, Ruby Wasti, Lucinda Thiede, Joshua Tagore, Jacqueline Larouche, Marie Marcher, Sarah O’Brien, Jeanine Pignatelli, Kang Liu, Ben Stanger, Ellen Pure, Varenka Rodriguez DiBlasi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/0c3c04dd78ed4944b2d18ac5fc00c2e2
Autor:
Dongfeng Qu, Jeremy Johnson, Parthasarathy Chandrakesan, Nathaniel Weygant, Randal May, Nicole Aiello, Andrew Rhim, Lichao Zhao, Wei Zheng, Stanley Lightfoot, Shubham Pant, Jeremy Irvan, Russell Postier, James Hocker, Jay S Hanas, Naushad Ali, Sripathi M Sureban, Guangyu An, Michael J Schlosser, Ben Stanger, Courtney W Houchen
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0118933 (2015)
Doublecortin-like kinase 1 (DCLK1) is a putative pancreatic stem cell marker and is upregulated in pancreatic cancer, colorectal cancer, and many other solid tumors. It marks tumor stem cells in mouse models of intestinal neoplasia. Here we sought to
Externí odkaz:
https://doaj.org/article/f252e7d7a9a5466fb4e873020e5443fe
Autor:
Nune Markosyan, Charu Arora, Liz Quinones, Il-Kyu Kim, Nikhil Joshi, Noah Cheng, John Tobias, Ben Stanger, Robert Vonderheide
Publikováno v:
Cancer Research. 83:3276-3276
Pancreatic adenocarcinoma (PDA) is the third leading cause of cancer-related deaths in the US partly because of its resistance to conventional chemotherapies. Immunotherapies that improve survival in many cancers, almost universally fail in PDA. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::928fa4f0c6949f86c0cf2e0cd8b900ce
https://doi.org/10.1158/1538-7445.am2023-3276
https://doi.org/10.1158/1538-7445.am2023-3276
Autor:
Ben Stanger
Publikováno v:
Cancer Research. 83:IA017-IA017
Recurrent single nucleotide mutations are a common feature of primary tumor evolution, where mutations in genes such as KRAS, APC, TP53, and BRAF are important drivers of malignancy. Efforts to identify comparable mutations that are exclusive to meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12cf6ce593b4017b6a03f9a8b32e84f1
https://doi.org/10.1158/1538-7445.metastasis22-ia017
https://doi.org/10.1158/1538-7445.metastasis22-ia017
Autor:
Gauri Mirji, Alison Worth, Sajad Bhat, Mohamed Sayed, Toshitha Kannan, Aaron Goldman, Hsin-Yao Tang, Qin Liu, Noam Auslander, Chi Dang, Mohamed Abdel-Mohsen, Andrew Kossenkov, Ben Stanger, Rahul Shinde
Publikováno v:
Cancer Research. 82:C023-C023
The composition of the gut microbiome controls innate and adaptive immunity and has emerged as a key regulator of tumor growth and the success of immune checkpoint blockade (ICB) therapy. However, the underlying mechanisms remain unclear. Pancreatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::352b652e8b951ec089bb00c7ee35f959
https://doi.org/10.1158/1538-7445.panca22-c023
https://doi.org/10.1158/1538-7445.panca22-c023
Autor:
Samantha B. Kemp, Andrei Georgescu, Jason Pitarresi, Takeshi Katsuda, Il-Kyu Kim, Dora Racca, John Tobias, Dan Huh, Ben Stanger
Publikováno v:
Cancer Research. 82:C069-C069
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy that is overwhelmingly resistant to therapy. PDAC tumors are characterized by an immunosuppressive fibroinflammatory stroma and can be broadly classified into those with an abundance of T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4abcb1fc79706ba80788d597e931bf8b
https://doi.org/10.1158/1538-7445.panca22-c069
https://doi.org/10.1158/1538-7445.panca22-c069
Autor:
Erin Hollander, Ben Stanger
Publikováno v:
Cancer Research. 82:C006-C006
Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer-related death in the United States. The five-year survival rate of less than nine percent is attributed mainly to a difficulty in early detection and a lack of eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20989dc1440ace9635caff16a2dd7493
https://doi.org/10.1158/1538-7445.panca22-c006
https://doi.org/10.1158/1538-7445.panca22-c006
Autor:
Paul C. McDonald, Wells S. Brown, Zack Gerbec, Shannon Awrey, Joanna Karasinska, David Schaeffer, Daniel Renouf, Ben Stanger, Shoukat Dedhar
Publikováno v:
Cancer Research. 82:5997-5997
Neutrophils and neutrophil extracellular traps (NETs) contribute to the hypoxic, immunosuppressive pancreatic ductal adenocarcinoma (PDAC) tumour microenvironment (TME) which promotes treatment resistance, increased invasion and metastasis. While rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fbc9b90bfa1a4fe12ecedf06169a490
https://doi.org/10.1158/1538-7445.am2022-5997
https://doi.org/10.1158/1538-7445.am2022-5997
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.